Montrose Environmental Group (MEG) Q3 2024 earnings summary

Executive summary

• Achieved record Q3 2024 revenue of $178.7M, up 6.4% year-over-year, and record nine-month revenue of $507.4M, driven by organic growth and acquisitions, despite lower emergency response and treatment technology revenues.

• Q3 consolidated adjusted EBITDA reached $28.3M (15.8% margin), up 21.5% year-over-year, with margin expansion driven by higher-margin services and operational efficiency.

• Diluted adjusted net income per share was $0.41 in Q3, up from $0.31 in the prior year; Q3 net loss was $10.6M, mainly due to higher interest expense.

• Six acquisitions completed in 2024, including Spirit Environmental and Origins Laboratory, expanded capabilities and contributed $26.6M in revenue.

• Operating cash flow was negative $9.7M for the nine months ended September 30, 2024, due to higher receivables and integration-related delays, but is expected to improve in Q4.

Financial highlights

• Q3 2024 revenue: $178.7M (up 6.4% year-over-year); nine months: $507.4M (up 10.7%).

• Q3 consolidated adjusted EBITDA: $28.3M (15.8% margin), up from $23.3M (13.9%) a year ago; nine-month adjusted EBITDA: $68.5M (13.5% margin).

• Q3 adjusted net income: $19.1M; Q3 net loss: $10.6M; Q3 adjusted EPS: $0.41; Q3 net loss per share: $(0.39).

• Year-to-date cash flow from operations was negative $9.7M, mainly due to higher receivables and contract assets.

• Interest expense increased to $4.1M in Q3 2024, reflecting higher rates and debt balances.

Outlook and guidance

• Reaffirmed full-year 2024 guidance: revenue of $690M–$740M and consolidated adjusted EBITDA of $95M–$100M.

• Q4 2024 revenue expected to grow 10–15% year-over-year, with EBITDA margin up 350–400 basis points.

• PFAS-related revenue in laboratories expected to rise ~30% and consulting services ~75% in 2024 versus 2023.

• Guidance excludes any benefit from future acquisitions.

• Management remains confident in growth trajectory, citing regulatory tailwinds and resilient demand.